Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma
Clinical trial NCT04361331 · COMPLETED
Trial details
- NCT number
- NCT04361331
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-06
- Primary completion
- 2023-09-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.